GFACX | PNOYX | GFACX / PNOYX | |
Total Expense Ratio | 1.36 | 0.62 | 219% |
Annual Report Gross Expense Ratio | 1.36 | 0.62 | 219% |
Fund Existence | 24 years | 31 years | - |
Gain YTD | 10.759 | 1.477 | 728% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 320B | 6.37B | 5,024% |
Annual Yield % from dividends | 0.00 | 0.62 | - |
Returns for 1 year | 8.68 | -3.56 | -244% |
Returns for 3 years | 52.72 | 37.66 | 140% |
Returns for 5 years | 39.40 | 32.47 | 121% |
Returns for 10 years | 67.66 | 76.06 | 89% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CWIFX | 71.28 | 0.46 | +0.65% |
American Funds Capital World Gr&Inc 529F | |||
WCEAX | 18.43 | N/A | N/A |
Macquarie Core Equity Fund Class A | |||
ETAHX | 32.75 | N/A | N/A |
Eventide Healthcare & Life Sciences A | |||
BLRAX | 11.71 | N/A | N/A |
Brookfield Global Listed Real Estate A | |||
RCMPX | 17.82 | N/A | N/A |
Lazard International Quality Gr R6 |